Elisabetta Aldieri

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 11

Top Venues

Cancers

International journal of molecular sciences

Pharmaceutics

Clinical cancer research : an official journal of the American Association for Cancer Research

Università degli Studi di Torino

Università degli Studi di Torino (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Università degli Studi di Torino Jan 01 2005

Italy

Assistant Professor of Biochemistry (BIO/10) :: Oncology

Education History

Università degli Studi di Torino Oct 01 1987 - Jul 06 1995

Italy

PHD :: Genetic, Biology and Biochemistry

Publications

Cristina Favaron, Ludovica Gaiaschi, Claudio Casali, Fabrizio De Luca, Federica Gola, Margherita Cavallo, Valeria Ramundo, Elisabetta Aldieri, Gloria Milanesi, Silvia Damiana Visonà, Mauro Ravera, Maria Grazia Bottone
Unraveling Novel Strategies in Mesothelioma Treatments Using a Newly Synthetized Platinum(IV) Compound. Pharmaceutics 16 (8) (2024)
Cristina Favaron, Ludovica Gaiaschi, Claudio Casali, Fabrizio De Luca, Federica Gola, Margherita Cavallo, Valeria Ramundo, Elisabetta Aldieri, Gloria Milanesi, Silvia Damiana Visonà, Mauro Ravera, Maria Grazia Bottone
Unraveling Novel Strategies in Mesothelioma Treatments Using a Newly Synthetized Platinum(IV) Compound. Pharmaceutics 16 (8) (2024)
Valeria Ramundo, Maria Luisa Palazzo, Elisabetta Aldieri
TGF-β as Predictive Marker and Pharmacological Target in Lung Cancer Approach. Cancers 15 (8) (2023)
Dario P Anobile, Iris Chiara Salaroglio, Fabrizio Tabbò, Sofia La Vecchia, Muhlis Akman, Francesca Napoli, Maristella Bungaro, Federica Benso, Elisabetta Aldieri, Paolo Bironzo, Joanna Kopecka, Francesco Passiglia, Luisella Righi, Silvia Novello, Giorgio Vittorio Scagliotti, Chiara Riganti
Autocrine 17-β-estradiol/estrogen receptor-α loop determines the response to immune-checkpoint inhibitors in non-small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Valeria Ramundo, Giada Zanirato, Maria Luisa Palazzo, Chiara Riganti, Elisabetta Aldieri
APE-1/Ref-1 Inhibition Blocks Malignant Pleural Mesothelioma Cell Proliferation and Migration: Crosstalk between Oxidative Stress and Epithelial Mesenchymal Transition (EMT) in Driving Carcinogenesis and Metastasis. International journal of molecular sciences 24 (16) (2023)
Valeria Ramundo, Maria Luisa Palazzo, Elisabetta Aldieri
TGF-β as Predictive Marker and Pharmacological Target in Lung Cancer Approach. Cancers 15 (8) (2023)
Valeria Ramundo, Giuliana Giribaldi, Elisabetta Aldieri
Transforming Growth Factor-β and Oxidative Stress in Cancer: A Crosstalk in Driving Tumor Transformation. Cancers 13 (12) (2021)
Martina Schiavello, Elena Gazzano, Loredana Bergandi, Francesca Silvagno, Roberta Libener, Chiara Riganti, Elisabetta Aldieri
Identification of Redox-Sensitive Transcription Factors as Markers of Malignant Pleural Mesothelioma. Cancers 13 (5) (2021)
Valeria Ramundo, Giada Zanirato, Elisabetta Aldieri
The Epithelial-to-Mesenchymal Transition (EMT) in the Development and Metastasis of Malignant Pleural Mesothelioma. International journal of molecular sciences 22 (22) (2021)
Arianna Marucco, Elisabetta Aldieri, Riccardo Leinardi, Enrico Bergamaschi, Chiara Riganti, Ivana Fenoglio
Applicability and Limitations in the Characterization of Poly-Dispersed Engineered Nanomaterials in Cell Media by Dynamic Light Scattering (DLS). Materials (Basel, Switzerland) 12 (23) (2019)
Stefano Turini, Loredana Bergandi, Elena Gazzano, Mauro Prato, Elisabetta Aldieri
Epithelial to Mesenchymal Transition in Human Mesothelial Cells Exposed to Asbestos Fibers: Role of TGF-β as Mediator of Malignant Mesothelioma Development or Metastasis via EMT Event. International journal of molecular sciences 20 (1) (2019)

Elisabetta Aldieri.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Elisabetta Aldieri